Medscape Medical News
- Alert FDA Approves New Drug, Sotagliflozin, for Heart Failure
- Alert FDA Advisory Committee Votes Against Approval for NASH Drug
- Alert FDA Approves Epcoritamab for r/r B-Cell Lymphoma
- Alert FDA Clears iLet Bionic Pancreas Insulin Delivery System
- FDA OKs Stem Cell Therapy to Reduce Infection Risk
- FDA Clears First Patch to Treat Axillary Hyperhidrosis
- Alert FDA Approves New Merkel Cell Carcinoma Drug Zynyz
- Alert FDA Approves Zavegepant Nasal Spray for Acute Migraine
- Alert Two FDA Clearances Add Diabetes Technology Options
- Alert FDA Approves Once-Weekly Product for Hemophilia A
- Alert FDA OKs Sparsentan for Rare Kidney Disease
- Alert FDA OKs First Drug for Geographic Atrophy, a Major Cause of Adult Blindness
- Alert FDA Approves Abrocitinib for Teens With Atopic Dermatitis
- Alert FDA OKs Pembrolizumab for Adjuvant Treatment of NSCLC
- Alert Tucatinib Plus Trastuzumab Approved for HER2+ CRC
- Alert FDA Approves Second Anti-Amyloid for Alzheimer's Disease
- Alert FDA Approves First-in-Class Drug for Follicular Lymphoma
- Alert FDA Approves Abaloparatide (Tymlos) for Osteoporosis in Men
- Alert Adagrasib (Krazati) Approved for KRAS-Mutated NSCLC
- Alert FDA Approves Olutasidenib (Rezlidhia) for Certain Patients With AML